Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins
通过阻断 Tau 与含 SH3 蛋白的相互作用来预防阿尔茨海默病的癫痫发作和相关记忆丧失
基本信息
- 批准号:9817263
- 负责人:
- 金额:$ 38.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAblationAdultAffinityAgonistAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmino Acid SubstitutionAmino AcidsAmyloid beta-ProteinAmyloid beta-Protein PrecursorAttentionBehaviorBehavioralBindingBinding ProteinsBiochemicalBiological AssayBrainComplementDataDiseaseElectrophysiology (science)EnzymesEpilepsyEpileptogenesisExcitatory NeurotoxinsExhibitsFunctional disorderGeneticGlutamate ReceptorGlutamatesGoalsHippocampus (Brain)HumanHyperactive behaviorImpaired cognitionJ20 mouseKnock-inKnock-in MouseKnowledgeLeadLigationLinkLongevityMAPT geneMagnetic Resonance ImagingMeasuresMediatingMemory LossMissionModelingMusMutationN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNamesNeurodegenerative DisordersNeuronsOutcomePLC gamma1PXXP MotifPathogenesisPatientsPeptidesPharmacologyPredispositionPremature MortalityPreventionPrevention approachPreventive InterventionProcessProline-Rich DomainProteinsProto-Oncogene Proteins c-fynPublic HealthRecombinant ProteinsRegulatory ElementResearchResistanceSafetySeizuresSignal TransductionSliceSynapsesTauopathiesTestingTherapeutic InterventionTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthVariantWorkadverse outcomeagedbasebrain sizeexcitotoxicityfamilial Alzheimer diseaseglutamatergic signalinginnovationknock-downmouse modelneuronal excitabilitynoveloverexpressionpreventprotective effectprotein complexreceptorresponsesynaptic functiontargeted treatmenttau Proteinstau interactiontau mutation
项目摘要
PROJECT SUMMARY
Up to 60% of patients with Alzheimer’s disease (AD) exhibit seizures and network hyperactivity, leading to a
faster cognitive decline. Therefore, seizures in AD should be an important focus for therapeutic interventions.
The microtubule-associated protein tau, a central factor in AD pathogenesis, mediates seizures and associated
memory loss in models of AD, suggesting that targeting tau could effectively treat seizures in AD. However, there
is a fundamental gap in understanding how tau contributes to seizures in these models. Broadly reducing tau
levels successfully prevents seizures; however, reducing tau also causes deleterious effects in aged mice and
the safety of this approach in the adult human brain is unknown. Therefore, a better understanding of how tau
contributes to seizures is needed in order to develop more precise therapies targeting tau. The overall objective
here is to identify a mechanism by which tau mediates seizures and related functional deficits in mouse models
of AD and genetic epilepsy. The applicant has obtained preliminary data indicating that blocking tau’s interactions
with SRC Homology 3 (SH3)-containing proteins can prevent seizures and associated memory loss in AD. The
central hypothesis, based on the applicant’s preliminary data, is that tau binds to SH3-containing enzymes on its
proline-rich region, and regulates network activity by modulating the activity or cellular localization of these
enzymes. Previous studies, supportive of this concept, have indicated that binding between tau and the tyrosine
kinase Fyn, which regulates excitatory receptors, are involved in tau’s ability to regulate seizures. The applicant’s
preliminary data expands on these findings to indicate additional SH3-containing enzymes that bind tau and are
involved in this phenomenon. The rationale for the proposed research is that, once it is known which enzymes
are important for tau’s ability to mediate seizures, tau’s binding affinity with these enzymes can be manipulated
pharmacologically, resulting in new and innovative approaches to the prevention and treatment of seizures and
associated memory loss in AD. Guided by strong preliminary data in which the applicant created two novel
mutant tau knockin mouse models, this hypothesis will be tested by pursuing two specific aims: 1) Determine
the influence of variants in the proline-rich region of tau that prevent its binding to SH3-containing enzymes on
signal transduction initiated by Aβ oligomers, which are epileptogenic peptides linked to AD, and excitotoxins,
and 2) Determine the extent to which these variants in tau prevent seizures, behavioral deficits, and premature
mortality in mouse models of AD and genetic epilepsy. The proposed research is innovative because it
represents a substantive departure from the status quo by shifting focus to tau’s upstream modulation of cell
signaling related to Aβ and excitotoxicity. This contribution is expected to be significant because it will have broad
translational importance in the prevention and treatment of seizures and associated memory loss in AD.
项目概要
高达 60% 的阿尔茨海默病 (AD) 患者会出现癫痫发作和网络过度活跃,从而导致
认知能力下降更快。因此,AD 的癫痫发作应成为治疗干预的重点。
微管相关蛋白 tau 是 AD 发病机制的核心因素,介导癫痫发作和相关的
AD 模型中的记忆丧失,表明靶向 tau 蛋白可以有效治疗 AD 癫痫发作。然而,有
在理解这些模型中 tau 蛋白如何导致癫痫发作方面存在根本性的差距。广泛减少 tau
水平成功预防癫痫发作;然而,减少 tau 蛋白也会对老年小鼠产生有害影响
这种方法在成年人脑中的安全性尚不清楚。因此,更好地了解 tau
为了开发针对 tau 的更精确疗法,需要对癫痫发作做出贡献。总体目标
目的是确定 tau 介导小鼠模型癫痫发作和相关功能缺陷的机制
AD 和遗传性癫痫。申请人已获得初步数据表明阻断 tau 相互作用
含有 SRC 同源 3 (SH3) 的蛋白质可以预防 AD 中的癫痫发作和相关的记忆丧失。这
根据申请人的初步数据,中心假设是 tau 与其上含有 SH3 的酶结合
富含脯氨酸的区域,并通过调节这些区域的活性或细胞定位来调节网络活动
酶。先前的研究支持了这一概念,表明 tau 蛋白和酪氨酸之间的结合
调节兴奋性受体的激酶 Fyn 参与 tau 调节癫痫发作的能力。申请人的
初步数据扩展了这些发现,表明还有其他含有 SH3 的酶可以结合 tau,并且
参与这一现象。拟议研究的基本原理是,一旦知道哪些酶
对于 tau 介导癫痫发作的能力很重要,tau 与这些酶的结合亲和力可以被操纵
药理学上,产生了预防和治疗癫痫发作的新方法和创新方法
AD 相关的记忆丧失。在强有力的初步数据的指导下,申请人创造了两种新颖的
突变 tau 基因敲入小鼠模型中,该假设将通过追求两个特定目标进行检验:1) 确定
tau 富含脯氨酸区域的变异的影响,阻止其与含有 SH3 的酶结合
由 Aβ 寡聚物启动的信号转导,Aβ 寡聚物是与 AD 相关的致癫痫肽和兴奋毒素,
2) 确定 tau 蛋白变异在多大程度上预防癫痫发作、行为缺陷和早产儿
AD 和遗传性癫痫小鼠模型的死亡率。拟议的研究具有创新性,因为它
通过将焦点转移到 tau 的上游细胞调节上,代表了对现状的实质性背离
与 Aβ 和兴奋性毒性相关的信号传导。预计这一贡献将是巨大的,因为它将具有广泛的影响
在预防和治疗 AD 癫痫发作和相关记忆丧失方面具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith Alan Vossel其他文献
Keith Alan Vossel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keith Alan Vossel', 18)}}的其他基金
Leveraging the Electronic Health Record and Integrating Social and Biological Data to Expand Dementia Research in Understudied Populations in Los Angeles County
利用电子健康记录并整合社会和生物数据,扩大洛杉矶县未受研究人群的痴呆症研究
- 批准号:
10729950 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins.
通过阻断 Tau 与含 SH3 蛋白的相互作用来预防阿尔茨海默病的癫痫发作和相关记忆丧失。
- 批准号:
10392443 - 财政年份:2020
- 资助金额:
$ 38.5万 - 项目类别:
Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins.
通过阻断 Tau 与含 SH3 蛋白的相互作用来预防阿尔茨海默病的癫痫发作和相关记忆丧失。
- 批准号:
10599226 - 财政年份:2020
- 资助金额:
$ 38.5万 - 项目类别:
Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins.
通过阻断 Tau 与含 SH3 蛋白的相互作用来预防阿尔茨海默病的癫痫发作和相关记忆丧失。
- 批准号:
10254947 - 财政年份:2020
- 资助金额:
$ 38.5万 - 项目类别:
Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins.
通过阻断 Tau 与含 SH3 蛋白的相互作用来预防阿尔茨海默病的癫痫发作和相关记忆丧失。
- 批准号:
10171747 - 财政年份:2020
- 资助金额:
$ 38.5万 - 项目类别:
Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins
通过阻断 Tau 与含 SH3 蛋白的相互作用来预防阿尔茨海默病的癫痫发作和相关记忆丧失
- 批准号:
9979720 - 财政年份:2019
- 资助金额:
$ 38.5万 - 项目类别:
Mechanisms and Treatment of Network Dysfunction in Alzheimer's Disease
阿尔茨海默病网络功能障碍的机制和治疗
- 批准号:
8189497 - 财政年份:2011
- 资助金额:
$ 38.5万 - 项目类别:
Mechanisms and Treatment of Network Dysfunction in Alzheimer's Disease
阿尔茨海默病网络功能障碍的机制和治疗
- 批准号:
8508778 - 财政年份:2011
- 资助金额:
$ 38.5万 - 项目类别:
Mechanisms and Treatment of Network Dysfunction in Alzheimer's Disease
阿尔茨海默病网络功能障碍的机制和治疗
- 批准号:
8892948 - 财政年份:2011
- 资助金额:
$ 38.5万 - 项目类别:
Mechanisms and Treatment of Network Dysfunction in Alzheimer's Disease
阿尔茨海默病网络功能障碍的机制和治疗
- 批准号:
8319396 - 财政年份:2011
- 资助金额:
$ 38.5万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Standard Grant